• News
  • SAN DIEGO
  • Finance

Neurocrine 4Q profit jumps due to collaboration

Neurocrine Biosciences Inc.'s fourth-quarter earnings swelled, as the drug developer brought in more revenue from its collaboration on elagolix, an experimental treatment for endometriosis pain.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!